Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

F Taga

Showing results (11-20 of 20) with videos related to

Pageof 2
Sort By:
You have reached the last page of results.This site can display upto 20 results.
Arzneimittel-Forschung|January 1, 1992
Protective effect of the new antiplatelet agent 2-methyl-3-(1,4,5,6-tetrahydronicotinoyl)pyrazolo[1,5-a]pyridine on myocardial damage due to coronary occlusion and reperfusion in rabbitS Ohmuro, Y Tsukada, F Taga, et al.
Arzneimittel-Forschung|January 1, 1992
Antiplatelet effects of 2-methyl-3-(1,4,5,6-tetrahydronicotinoyl)pyrazolo[1,5-a]pyridine in relation to its disposition in rats, rabbits and dogsS Ohmuro, T Sasahara, F Taga, et al.
Arzneimittel-Forschung|February 1, 1993
Pharmacological profiles of the new histamine H2-receptor antagonist N-ethyl-N'-[3-[3-(piperidinomethyl)phenoxy] propyl] ureaH Sekiguchi, K Hamada, F Kobayashi, et al.
Nihon Yakurigaku Zasshi. Folia Pharmacologica Japonica|February 1, 1996
[Influence of KU-1257 on the recurrence and relapse of acetic acid-induced chronic gastric ulcers in rats]H Sekiguchi, A Ohsawa, F Kobayashi, et al.
Arzneimittel-Forschung|February 1, 1993
Healing-promoting action of the new histamine H2-receptor antagonist N-ethyl-N'-[3-[3-(piperidinomethyl)phenoxy]propyl]urea with dual action on chronic gastric and duodenal ulcers induced by acetic acid in ratsH Sekiguchi, K Hamada, H Aijima, et al.
Arzneimittel-Forschung|August 1, 1990
Possibility for induction of convulsion by fleroxacin and its disposition in the central nervous system in animalsF Taga, F Kobayashi, S Saito, et al.
Journal of Medicinal Chemistry|June 26, 1992
Synthesis and antiulcer activity of N-substituted N'-[3-[3-(piperidinomethyl)phenoxy]propyl]ureas: histamine H2-receptor antagonists with a potent mucosal protective activityM Miyashita, T Matsumoto, H Matsukubo, et al.
Cell Reports|August 23, 2023
Cell-type-specific regulation of APOE and CLU levels in human neurons by the Alzheimer's disease risk gene SORL1Hyo Lee, Aimee J Aylward, Richard V Pearse, et al.
Nature Communications|December 1, 2020
Single cell RNA sequencing of human microglia uncovers a subset associated with Alzheimer's diseaseMarta Olah, Vilas Menon, Naomi Habib, et al.
Biorxiv : the Preprint Server for Biology|August 6, 2025
CD33 and clusterin interact biophysically and genetically to modulate Alzheimer riskRoger B Dodd, Masahiro Enomoto, Ye Zhou, et al.
Pageof 2

Showing results (11-20 of 20) with videos related to

Sort By:
Pageof 2
You have reached the last page of results.This site can display upto 20 results.
Arzneimittel-Forschung|January 1, 1992
Protective effect of the new antiplatelet agent 2-methyl-3-(1,4,5,6-tetrahydronicotinoyl)pyrazolo[1,5-a]pyridine on myocardial damage due to coronary occlusion and reperfusion in rabbitS Ohmuro, Y Tsukada, F Taga, et al.
Arzneimittel-Forschung|January 1, 1992
Antiplatelet effects of 2-methyl-3-(1,4,5,6-tetrahydronicotinoyl)pyrazolo[1,5-a]pyridine in relation to its disposition in rats, rabbits and dogsS Ohmuro, T Sasahara, F Taga, et al.
Arzneimittel-Forschung|February 1, 1993
Pharmacological profiles of the new histamine H2-receptor antagonist N-ethyl-N'-[3-[3-(piperidinomethyl)phenoxy] propyl] ureaH Sekiguchi, K Hamada, F Kobayashi, et al.
Nihon Yakurigaku Zasshi. Folia Pharmacologica Japonica|February 1, 1996
[Influence of KU-1257 on the recurrence and relapse of acetic acid-induced chronic gastric ulcers in rats]H Sekiguchi, A Ohsawa, F Kobayashi, et al.
Arzneimittel-Forschung|February 1, 1993
Healing-promoting action of the new histamine H2-receptor antagonist N-ethyl-N'-[3-[3-(piperidinomethyl)phenoxy]propyl]urea with dual action on chronic gastric and duodenal ulcers induced by acetic acid in ratsH Sekiguchi, K Hamada, H Aijima, et al.
Arzneimittel-Forschung|August 1, 1990
Possibility for induction of convulsion by fleroxacin and its disposition in the central nervous system in animalsF Taga, F Kobayashi, S Saito, et al.
Journal of Medicinal Chemistry|June 26, 1992
Synthesis and antiulcer activity of N-substituted N'-[3-[3-(piperidinomethyl)phenoxy]propyl]ureas: histamine H2-receptor antagonists with a potent mucosal protective activityM Miyashita, T Matsumoto, H Matsukubo, et al.
Cell Reports|August 23, 2023
Cell-type-specific regulation of APOE and CLU levels in human neurons by the Alzheimer's disease risk gene SORL1Hyo Lee, Aimee J Aylward, Richard V Pearse, et al.
Nature Communications|December 1, 2020
Single cell RNA sequencing of human microglia uncovers a subset associated with Alzheimer's diseaseMarta Olah, Vilas Menon, Naomi Habib, et al.
Biorxiv : the Preprint Server for Biology|August 6, 2025
CD33 and clusterin interact biophysically and genetically to modulate Alzheimer riskRoger B Dodd, Masahiro Enomoto, Ye Zhou, et al.
Pageof 2